Knowing Mycellf™: Personalized Medicine and the Economization of Prospective Knowledge about Bodily Fate

Bronwyn Parry*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

5 Citations (Scopus)

Abstract

The author explores the emergence of direct-to-consumer (DTC) genetic testing as a means of economizing information or knowledge about “bodily fate.” She begins by examining the parallels and incommensurabilities between the kinds of bodily information that have been produced historically and those now generated by the application of advanced genome sequencing technologies. She then explores how contemporary understandings of disease are coproduced by individuals identified as potential constituents of disease communities by these forms of testing. The chapter concludes with a review of the implications that this involvement in the coproduction of understanding of disease has for the global regulation of DTC genetic testing.

Original languageEnglish
Title of host publicationKnowledge and the Economy
Place of PublicationDordrecht
PublisherSpringer Nature
Pages157-171
Number of pages15
Volume5
ISBN (Electronic)978-94-007-6131-5
ISBN (Print)978-94-007-6130-8
DOIs
Publication statusPublished - 6 Mar 2013
Externally publishedYes

Publication series

NameKnowledge and Space
Volume5
ISSN (Print)1877-9220
ISSN (Electronic)2543-0580

Fingerprint

Dive into the research topics of 'Knowing Mycellf™: Personalized Medicine and the Economization of Prospective Knowledge about Bodily Fate'. Together they form a unique fingerprint.

Cite this